These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2065846)

  • 21. Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients.
    Pigon J; Giacca A; Ostenson CG; Lam L; Vranic M; Efendic S
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3702-8. PubMed ID: 8855826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
    Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
    Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
    Giordano M; Matsuda M; Sanders L; Canessa ML; DeFronzo RA
    Diabetes; 1995 Jun; 44(6):665-71. PubMed ID: 7789631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.
    Lewis GF; Carpentier A; Vranic M; Giacca A
    Diabetes; 1999 Mar; 48(3):570-6. PubMed ID: 10078558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.
    Dorella M; Giusto M; Da Tos V; Campagnolo M; Palatini P; Rossi G; Ceolotto G; Felice M; Semplicini A; Del Prato S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1568-74. PubMed ID: 8636369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose and fatty acid metabolism in type 2 diabetes mellitus: an assessment using low-dose insulin infusion and the hyperinsulinaemic euglycaemic clamp.
    Webber J; Whitelaw D; Smith JM; Nattrass M
    Diabetes Obes Metab; 1999 May; 1(3):173-8. PubMed ID: 11220296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment.
    Bak JF; Møller N; Schmitz O; Saaek A; Pedersen O
    Diabetologia; 1992 Aug; 35(8):777-84. PubMed ID: 1511806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition.
    Ferri C; Laurenti O; Bellini C; Faldetta MR; Properzi G; Santucci A; De Mattia G
    Am J Hypertens; 1995 Jan; 8(1):40-7. PubMed ID: 7734095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute changes in plasma non-esterified fatty acid concentration do not change hepatic glucose production in people with type 2 diabetes.
    Johnston P; Hollenbeck C; Sheu W; Chen YD; Reaven GM
    Diabet Med; 1990 Dec; 7(10):871-5. PubMed ID: 2149683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
    Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
    Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance is associated with high plasma ouabain-like immunoreactivity concentration in NIDDM.
    Wasada T; Kuroki H; Naruse M; Arii H; Maruyama A; Katsumori K; Saito S; Watanabe Y; Naruse K; Demura H
    Diabetologia; 1995 Jul; 38(7):792-7. PubMed ID: 7556980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral and hepatic insulin sensitivity in non-insulin-dependent diabetes mellitus: effect of nonesterified fatty acids.
    Walker M; Agius L; Orskov H; Alberti KG
    Metabolism; 1993 May; 42(5):601-8. PubMed ID: 8492715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM.
    Widén EI; Eriksson JG; Groop LC
    Diabetes; 1992 Mar; 41(3):354-8. PubMed ID: 1551495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of glycogen stores and non-esterified fatty acid availability on insulin-stimulated glucose metabolism and tissue pyruvate dehydrogenase activity in the rat.
    Kruszynska YT; McCormack JG; McIntyre N
    Diabetologia; 1991 Apr; 34(4):205-11. PubMed ID: 2065855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus.
    Vuorinen-Markkola H; Yki-Järvinen H
    Metabolism; 1995 Jan; 44(1):85-9. PubMed ID: 7854171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased insulin-responsiveness by ACE-inhibition in noninsulin dependent diabetes mellitus.
    Rett K; Jauch KW; Wicklmayr M; Fink E; Dietze GJ; Mehnert H
    Adv Exp Med Biol; 1989; 247A():207-13. PubMed ID: 2557741
    [No Abstract]   [Full Text] [Related]  

  • 40. Essential hypertension and insulin resistance in non-insulin-dependent diabetes.
    Laakso M; Sarlund H; Mykkänen L
    Eur J Clin Invest; 1989 Dec; 19(6):518-26. PubMed ID: 2515972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.